The MAPK/ERK signaling pathway is one more essential target for inhibitors. Inhibitors targeting MAPK/ERK are employed in cancer cells treatments to avoid uncontrolled cell expansion and lump development.Antibiotics are a part of inhibitors that have changed the management of bacterial infections. By targeting bacterial cell walls, protein synthesi